Latest Conference Articles

BIO 2024: CDMOs Focus on Complex Technical Challenges to Boost Startup Biotechs

BIO 2024: CDMOs Focus on Complex Technical Challenges to Boost Startup Biotechs

October 29th 2024

Marianna Tcherpakov, PhD, director of Business Development, CMC Services, at Frontage Laboratories, spoke on the CDMO’s role in tackling complex technical challenges to enable startup biotechs solve scale up problems.

AAPS PharmSci 360 2024: Big Data and Variation in Excipient Production

AAPS PharmSci 360 2024: Big Data and Variation in Excipient Production

October 29th 2024

Pauline Janssen of DFE Pharma gave a presentation on the utility of analyzing big data sets to better understand and diagnose variability in the production process.

CPHI Milan 2024: Highlighting the Benefits of Integrated Services

CPHI Milan 2024: Highlighting the Benefits of Integrated Services

October 25th 2024

Pharmaceutical Technology Europe chats with Kevin Li, MBA, from BioDuro-Sundia about integrated services and the benefits these services can provide to pharma companies.

AAPS PharmSci 360: The Importance of HCP Analysis in Biomanufacturing

AAPS PharmSci 360: The Importance of HCP Analysis in Biomanufacturing

October 23rd 2024

Shawn Li, principal scientist at Merck & Co., known as MSD outside the Unites States and Canada, talked about the importance of properly characterizing HCPs in the biomanufacturing process.

AAPS PharmSci 360: LBFs and Tackling Oral Biologic Formulations

AAPS PharmSci 360: LBFs and Tackling Oral Biologic Formulations

October 22nd 2024

At AAPS PharmSci 360, Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer Health, at Catalent Pharma Solutions, discussed lipid-based formulations and tackling bioavailability challenges for oral biologics.

AAPS PharmSci 360: Challenges and Trends in Softgel Formulations

AAPS PharmSci 360: Challenges and Trends in Softgel Formulations

October 21st 2024

Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer Health, at Catalent Pharma Solutions, spoke on recent challenges and trends in softgel formulations.

AAPS PharmSci 306: Trends in New Analytical Tools for RNA Characterization

AAPS PharmSci 306: Trends in New Analytical Tools for RNA Characterization

October 21st 2024

Bala Addepalli, PhD, Director, R&D New Modalities Portfolio, Waters Corporation, discussed trends in new analytical tools for RNA characterization and gave highlights of his talk at AAPS PharmSci 360.

AAPS PharmSci 360: Advancements and Challenges in Large RNA Therapeutics

AAPS PharmSci 360: Advancements and Challenges in Large RNA Therapeutics

October 20th 2024

Bala Addepalli, PhD, Director, R&D New Modalities Portfolio, Waters Corporation, discussed recent advancements and current challenges in the development of large RNA therapeutics.

AAPS PharmSci 360 2024: How AI is Helping to Ensure Companies’ GMP Health

AAPS PharmSci 360 2024: How AI is Helping to Ensure Companies’ GMP Health

October 18th 2024

Redica Systems has been assisting pharmaceutical companies in determining GMP quality risks at their manufacturing sites, and with AI, it has a relatively new addition to its toolbox.

AAPS PharmSci 360 2024: The Future of Bioanalysis

AAPS PharmSci 360 2024: The Future of Bioanalysis

October 18th 2024

Xiao-Yan Cai, PhD, co-founder and CEO of Accurant Biotech, discussed collaborative efforts that must be undertaken between companies, and across scientific disciplines, to work together on continuing to develop medicines to save lives.